LZLiping Zhou

Liping Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liping Zhou has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Juan Xin

    Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University, 1 Yixueyuan Road, Chongqing 400016, China

    1 shared publication
  • Lili Sun

    Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University, 1 Yixueyuan Road, Chongqing 400016, China

    1 shared publication
  • Qian Tang

    School of Pharmacy, Chongqing Medical and Pharmaceutical College, 82 Middle College-City Road, Chongqing 401331, China

    1 shared publication
  • Shanshan Li

    Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University, 1 Yixueyuan Road, Chongqing 400016, China

    1 shared publication
  • Wei Li

    Department of Medicinal Chemistry, School of Pharmacy, Chongqing Medical University, Chongqing, China

    1 shared publication

Latest Publications

  • Open Access

    Facile Asymmetric Syntheses of Non-Natural Amino Acid (S)-Cyclopropylglycine by the Developed NADH-Driven Biocatalytic System

    by Qian Tang, Shanshan Li, Liping Zhou, Lili Sun, Juan Xin, Wei Li

    A self-sufficient bifunctional enzyme integrating reductive amination and coenzyme regeneration activities was developed and successfully employed to synthesize (S)-cyclopropylglycine with an improved reaction rate 2.1-fold over the native enzymes and a short bioconversion period of 6 h at a high substrate concentration of 120 g·L−1 and space–time yield of (S)-cyclopropylglycine up to 377.3 g·L−1·d−1, higher than that of any previously reported data. Additionally, (S)-cyclopropylglycine could be continuously synthesized for 90 h with the enzymes packed in a dialysis tube, providing 634.6 g of (S)-cyclopropylglycine with >99.5% ee and over 95% conversion yield up to 12 changes. These results confirmed that the newly developed NADH-driven biocatalytic system could be utilized as a self-sufficient biocatalyst for industrial application in the synthesis of (S)-cyclopropylglycine, which provides a chiral center and cyclopropyl fragment for the frequent synthesis of preclinical/clinical drug molecules.